We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Alpine Immune Sciences Inc is a clinical-stage biopharmaceutical company. It is engaged in discovering and developing innovative, protein-based immunotherapies to treat cancer and autoimmune and inflammatory diseases. The company's proprietary scientific platform uses a process known as directed evo... Alpine Immune Sciences Inc is a clinical-stage biopharmaceutical company. It is engaged in discovering and developing innovative, protein-based immunotherapies to treat cancer and autoimmune and inflammatory diseases. The company's proprietary scientific platform uses a process known as directed evolution to create therapeutics capable of modulating human immune system proteins. Its product pipeline includes ALPN-101 and ALPN-202. Show more
WINTER PARK, Fla., Nov. 19, 2024 (GLOBE NEWSWIRE) -- CTO Realty Growth, Inc. (NYSE: CTO) (the “Company” or “CTO”) announced today that its Board of Directors has authorized, and the Company has...
WINTER PARK, Fla., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Alpine Income Property Trust, Inc. (NYSE: PINE) (the “Company” or “PINE”) today announced that Jeffrey S. Yarckin has notified the Company of...
WINTER PARK, Fla., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Alpine Income Property Trust, Inc. (NYSE: PINE) (the “Company” or “PINE”), an owner and operator of single tenant net leased commercial...
WINTER PARK, Fla., Nov. 07, 2024 (GLOBE NEWSWIRE) -- CTO Realty Growth, Inc. (NYSE: CTO) (the “Company” or “CTO”) today announced the origination of a $40.2 million first mortgage loan with an...
WINTER PARK, Fla., Oct. 24, 2024 (GLOBE NEWSWIRE) -- CTO Realty Growth, Inc. (NYSE: CTO) (the “Company” or “CTO”) today announced its operating results and earnings for the quarter ended...
Apple (NASDAQ:AAPL) – iPhone 16 sales in China grew 20% in the first three weeks compared to its 2023 predecessor, driven by demand for Pro and Pro Max models, which increased 44%. Despite...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.06 | -0.340328984685 | 17.63 | 18.1 | 17.36 | 54185 | 17.65681079 | CS |
4 | -0.7 | -3.83141762452 | 18.27 | 18.5 | 17.36 | 73596 | 17.83325405 | CS |
12 | -1.28 | -6.79045092838 | 18.85 | 19.42 | 17.12 | 91368 | 18.05664703 | CS |
26 | 1.75 | 11.0619469027 | 15.82 | 19.42 | 14.76 | 64013 | 17.44605306 | CS |
52 | 1.74 | 10.9917877448 | 15.83 | 19.42 | 14.325 | 59390 | 16.73389413 | CS |
156 | -0.5 | -2.76701715551 | 18.07 | 21.069 | 14.25 | 68495 | 17.34695267 | CS |
260 | -1.43 | -7.52631578947 | 19 | 21.069 | 7.56 | 68856 | 17.11270512 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions